Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Gadolinium-Chelate

Review the clinical trials studying gadolinium-chelate on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-20 of 20

Identifying Findings on Brain Scans That Could Help Make Better Predictions about Brain Cancer Progression, The GABLE Trial
Status: Active
Location: 9 locations
Single Fraction Stereotactic Body Radiation Therapy Guided by Magnetic Resonance Imaging for the Treatment of Liver Metastasis from Colorectal Cancer
Status: Active
Location: 7 locations
Non-Invasive Focused Ultrasound with Oral Etoposide for the Treatment of Children with Progressive/Recurrent Diffuse Midline Glioma
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Status: Enrolling by Invitation
Location: Duke University Medical Center, Durham, North Carolina
Brain-Directed Stereotactic Radiation Therapy with or without AGulX Gadolinium-Based Nanoparticles for the Treatment of Brain Metastases
Status: Temporarily Closed to Accrual
Location: 2 locations
Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy with or without AGuIX for the Treatment of Central Lung Tumors and Locally Advanced Pancreatic Ductal Adenocarcinoma
Status: Temporarily Closed to Accrual
Location: 2 locations
Prednisone for Liver Protection in Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Status: Active
Location: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Rapid Motion-Robust Quantitative DCE-MRI for the Diagnosis of Gynecologic Cancer
Status: Active
Location: 3 locations
18F-FFNP PET/MRI for the Assessment of Early Response to Presurgical Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer
Status: Active
Location: 2 locations
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
[18F]FMISO-PET/MRI Scan for the Monitoring of Treatment Response in Patients with HER2+ Stage II-III Breast Cancer Receiving Therapy before Surgery
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Advanced Imaging Methods to Distinguish True Progression from Pseudoprogression in Patients with Brain Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Magnetic Resonance Imaging for Imaging of Tumor Microenvironment of Metastasis in Patients with Operable Breast Cancer
Status: Active
Location: Montefiore Medical Center-Weiler Hospital, Bronx, New York
Investigational Imaging Scans (AMRI, and DECT) in Guiding Biopsies of Primary Cerebral Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Contrast-Enhanced Imaging for Diagnosing Bladder Cancer Stage in Patients Undergoing Bladder Surgery
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Status: Active
Location: University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin
Developing a New Metabolic Imaging Approach (aMRI) for Diagnosing Neurological Disease in Patients with Gliomas
Status: Active
Location: OHSU Knight Cancer Institute, Portland, Oregon
Investigational Scans for the Prediction of Genetic Mutations in Patients with Glioma, ReGIT Study
Status: Temporarily Closed to Accrual
Location: 3 locations
Evaluating Advanced MRI Methods for Adapting Radiation Therapy for Patients with Newly Diagnosed High Grade Glioma
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York